theMednetRegister
J Immunother Cancer 2020 Oct
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.   

Related Questions

Given the results of LU002 presented at ASCO 2024, are there situations and/or patient subgroups who still derive benefit from local consolidative therapy for oligometastatic NSCLC?
New comment by Radiation Oncologist at San Francisco CyberKnife ( November 12, 2024)
Nothing Dr. Kittel wrote made any reference to RTOG 0617, nor does 0617 have a bearing on this topic.
Copyright © 2024 theMednet
All Rights Reserved.